These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4039078)

  • 1. A sensitive and specific assay for plasminogen activators.
    Smith DS; Harmon J; Owen WG
    Thromb Res; 1985 Feb; 37(4):533-41. PubMed ID: 4039078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators.
    Karlan BY; Clark AS; Littlefield BA
    Biochem Biophys Res Commun; 1987 Jan; 142(1):147-54. PubMed ID: 3101684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin-specific and effective clot lysis requires both plasminogen activators and for them to be in a sequential rather than simultaneous combination.
    Pannell R; Li S; Gurewich V
    J Thromb Thrombolysis; 2017 Aug; 44(2):210-215. PubMed ID: 28600623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activators in human malignant melanoma.
    Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
    J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasminogen activators and their physiological role].
    Andreenko GV
    Ukr Biokhim Zh (1978); 1983; 55(3):329-43. PubMed ID: 6346623
    [No Abstract]   [Full Text] [Related]  

  • 9. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G
    Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator and fibrinogen/fibrin degradation products at conization of the uterine cervix.
    Larsson G; Astedt B
    Acta Obstet Gynecol Scand; 1986; 65(4):331-3. PubMed ID: 3090852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of plasminogen activators in human gingival crevicular fluid.
    Brown JM; Watanabe K; Cohen RL; Chambers DA
    Arch Oral Biol; 1995 Sep; 40(9):839-45. PubMed ID: 8651888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary fibrin/fibrinogen derivatives.
    Hedner U
    Thromb Diath Haemorrh; 1975 Dec; 34(3):693-708. PubMed ID: 54945
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of affinities of urokinase and tissue plasminogen activator for fibrin clots.
    Homandberg GA; Wai T
    Thromb Res; 1989 Aug; 55(4):493-501. PubMed ID: 2510355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
    Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of plasminogen activator by normal, reactive and neoplastic human tissues cultured in vitro.
    Wilson EL; Dowdle E
    Int J Cancer; 1978 Oct; 22(4):390-9. PubMed ID: 700894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acoustic determination of performance and equivalence of plasminogen activators.
    Ghazali M; Hayward GL
    Anal Bioanal Chem; 2008 Nov; 392(5):897-902. PubMed ID: 18759103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
    Lipinski B; Gurewich V; Hyde E
    Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
    [No Abstract]   [Full Text] [Related]  

  • 18. [Enzymatic determination of plasminogen activators].
    Fischer BE
    Z Med Lab Diagn; 1988; 29(6):327-32. PubMed ID: 2973186
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
    Trübestein G; Popov S; Wolf H; Welzel D
    Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.